1. INTRODUCTION {#sec1-1}
===============

Osteoporosis and urolithiasis are two pathological entities presenting today all the more significant place in the epidemiological sense, for the reason of increased incidence rate and recidivism. As metabolic and chronic diseases, they are characterized with high morbidity and complications that may easily be followed with high mortality, a severe degree of disability, particularly in older population, which has significant medical, economical and social consequences to individuals and the overall society ([@ref1]-[@ref4]). Clinical research have discovered an increased bone disintegration and lower bone mass in the patients with urolithiasis, particularly when it comes to idiopathic calcium urolithiasis. Women in menopause are in a much higher risk to suffer because of a negative balance of calcium and reduced level of estrogen compared to men ([@ref5]-[@ref8]). Pathogenic mechanisms, which are connected to the occurrence of these diseases, are still in the phase of clinical research ([@ref9], [@ref10]). It is necessary to develop consciousness of the population about the risk factors related to the occurrence of these diseases and prevention measures that may contribute to their reduction ([@ref11]).

2. RESEARCH AIM {#sec1-2}
===============

Having in mind a great significance of these diseases, the aim of this work was to evaluate representation of osteoporosis, as established by the DEXA method, in patients with calcium osteoporosis with a special reflection onto the patients' gender.

3. MATERIAL AND METHODS {#sec1-3}
=======================

The research was a prospective one and it was performed at the University Hospital of the Clinical Center of Banja Luka, at the Urology Clinic and Clinic for Endocrinology, Diabetes and Metabolic Diseases. The material in this research consisted of the patients divided into three age sub-groups: 20-40, 40-60 and over 60. Ultrasonography was done for all the patients and the patients with ultrasonography findings, establishing urolithiasis, were candidates for the working group. They underwent additional diagnostic procedures of native X-ray scans of the urinary tract, intravenous urography and laboratory checks. Excluding factors were increased value of uric acid (uric stones), infectious (struvite) calculosis, taking of biophosphonates, hyperparathyroidism, the patients with malign diseases who were receiving hormone therapy (Ca of the prostate, Ca of the breast). The control group consisted of the population of patients, for whom, using initial ultrasound diagnostics, it was established that they do not suffer from urolithiasis. After that, the patients of the working and control group underwent densitometry using the instrument LUNAR DPX Product Division Americus GE Healthcare (GENERAL ELECTRIC COMPANY 2006), with the aim to measure mineral bone density, DXA L2-L4 of the lumbal spine and hip -- upper part of the femur, including the femur neck.

4. RESULTS {#sec1-4}
==========

Demographically observed, in the working group of 120 patients there were 40 persons in the three age categories: 20-40, 40-60 and over 60. The share of men was 52.5% and the share of women was 47.5%. Namely, the total number of men in the working group was 63, whereas the total number of women was 57, with an average age of 50.19.

By age and gender structure, the patients of the working group are shown in [Table 1](#T1){ref-type="table"}.
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Distribution of patients by age and gender structure (working group)
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Having analyzed the obtained results for the working group patients, by age structure, osteoporosis was more represented in women (14%) compared to men (1.6%). A higher representation of osteopenia was also found in women and it amounts to 22.8% compared to men, that of men being 17.5%. NAD results of the DEXA finding in women was also lower (63.2%) compared to that of men (81.0%), which was shown in [Table 2](#T2){ref-type="table"}.

###### 

Results of the DEXA finding by gender (working group)
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When observed in the total sample of the control group, where the patients, just as in the working group, were divided into three age categories (20-40, 40-60 and over 60), each having 40 patients, the share of women was somewhat higher, 60% (72 women), whereas the share of men was 40% (48 men), [Table 3](#T3){ref-type="table"}.
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Distribution of patients by age and gender structure (control group)
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Having analyzed the control group results, by gender structure, representation of osteopenia is much more expressed in women 36.1% compared to men being 2.1%; osteoporosis was present in 2.1% men and 0.0% women. Still, generally, because of predomination of osteopenia in women, NAD results of DEXA finding in women in also lower (63.9%) compared to men (95.8%), [Table 4](#T4){ref-type="table"}.

###### 

Results of the DEXA findins by gender (control group)
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Having observed the total sample of the working and control group, there was a statistically significant difference by gender representation of osteopenia and osteoporosis in women compared to men, that is, statistically, there was a much higher share of men with an NAD finding of DEXA, than it was the case with women, which is confirmed by the relation (p\< 0.01).

5. DISCUSSION {#sec1-5}
=============

Reference data confirm that clinical and epidemiological research have discovered in older patients with urolithiasis an increased bone remodeling and reduced mineral bone density (BMD). The reduced BMD is also supported by epidemic studies, which have shown that women in menopause with urolithiasis had a significantly higher incidence of low mineral bone density compared to male population, i.e. higher degrees of fracture compared to the control, primarily male, population ([@ref12]). It is considered that a limited input of calcium in food and its increased loss through the kidney work contributes to the occurrence of osteopenia/osteoporosis ([@ref13]). An additional problem in women, especially of older populations, presents a negative calcium balance, which is, during the menopause, doubled, as well as a surplus of hormones, such as parathyroid hormone (PTH) as well as a reduced estrogen level. All this may cause the loss of calcium with a consequential creation of calcium stones as well as increase of reduced mineral bone density (BMD) and development of osteopenia and osteoporosis of patients ([@ref14]-[@ref16]).

In line with the previously expressed positions and having analyzed the data of own research, our study has shown that in the total sample of the working group, by age structure, the representation of osteopenia/osteoporosis was much higher in women (22.8%, 14%) compared to men (17.5%, 1.6%); namely, NAD results of DEXA finding was much higher in men being 81% compared to that of women being 63.2%, which presents a statistically significant difference.

Having analyzed the obtained results of the DEXA finding in the control group of our study, by age representation, we can see that the share of women with osteopenia (36.1%) compared to men (2.1%), is significantly higher, which presents a statistically significant difference. Namely, NAD results of DEXA findings were much higher in men being 95.8% compared to women 63.9%.

6. CONCLUSION {#sec1-6}
=============

On the whole, the results of the implemented research confirm that representation of osteoporosis is much higher in women suffering from urolithiasis than in men. This is why prevention and adequate therapy are very significant components that should be undertaken as early as possible in order to avoid severe complications and consequences of these diseases.
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